Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Stereotactic ablative radiotherapy-driven immunosuppression is associated with poorer progression-free survival in cancer patients.

Cancer immunology, immunotherapy : CII·2025

Same author

OSCAR is an online ML-powered tool for organoid cell counting using bright-field images.

Cell reports methods·2025

Same author

TIM3 is a context-dependent coregulator of cytotoxic T cell function.

Science signaling·2025

Same author

LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025

Same author

"Mind the gap"- will we ever see equal median predicted survival for males and females in cystic fibrosis?

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025

Same author

Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4<sup>+</sup> T cell immunity.

Cell reports·2023

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Regulating the immune response to tumours.

Gareth J Betts¹, Sarah L Clarke, Hannah E Richards

¹Department of Medical Biochemistry and Immunology, Cardiff University, Henry Wellcome Building, Heath Park, Cardiff, CF14 4XN, UK.

Advanced Drug Delivery Reviews

|October 31, 2006

Summary

Regulatory T cells (Tregs) normally prevent autoimmunity but hinder anti-tumor immunity. Manipulating Tregs offers potential for cancer immunotherapy by promoting tumor rejection, though challenges exist.

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Related Experiment Videos

Last Updated: Jul 19, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Area of Science:

Immunology
Oncology
Cancer Research

Background:

Regulatory T cells (Tregs) are crucial for maintaining self-tolerance and preventing autoimmunity.
In cancer, Tregs can suppress beneficial anti-tumor immune responses, promoting tumor progression.
Understanding Treg function is vital for developing effective cancer immunotherapies.

Purpose of the Study:

To review the role of Tregs in cancer immunity.
To explore the potential of Treg manipulation for cancer immunotherapy.
To discuss the advantages and challenges associated with targeting Tregs in cancer treatment.

Main Methods:

Literature review of studies on Tregs in cancer.
Analysis of rodent models demonstrating Treg impact on tumor rejection.
Examination of clinical studies investigating Tregs in cancer patients.

Main Results:

Tregs suppress anti-tumor immune responses, contributing to tumor growth.
Removal or modulation of Tregs has shown promise in promoting tumor rejection in preclinical models.
Evidence suggests Tregs play a significant role in disease progression in cancer patients.

Conclusions:

Targeting Tregs is a promising strategy for enhancing cancer immunotherapy.
Further research is needed to overcome potential pitfalls and optimize Treg-based cancer treatments.
Manipulating Treg activity holds potential for improving patient outcomes in cancer therapy.